Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 27, 1997

View Archived Issues

MMP inhibitors synthesized by Otsuka

Japanese researchers describe anticoagulants

Taisho discloses promoters of NGF production

Selectin inhibitors from TBC

Selective nAChR ligands prepared by Novo Nordisk

Cytotoxic colchicine derivatives from Indena

Pfizer's new antifungal agents

Harvard College discloses vascular injury-associated gene

ArQule reports financial results for fourth quarter and year ended December 31, 1996

Cephalon announces 1996 financial results

Enzon reports second-quarter results

The Liposome Company reports fourth-quarter and 1996 results

Vion Pharmaceuticals reports fourth-quarter and year-end financial results

Mediator release inhibitors described by French investigators

Candidate proton pump inhibitor described by Dainippon

GSH deficiency linked to impaired survival in HIV/AIDS

Positive clinical results for inhaled indomethacin

Cell Genesys expands trials of AIDS gene therapy

Glaxo Wellcome evaluates ondansetron alone and in combination for emesis

Medicis acquires topical steroids

Positive results reported for VasoCare in MI

Axcan H. pylori trial nearing completion

AEterna codevelopment agreement for AE-941

Optivax phase I results reported at AAAI/AAI/CIS meeting

PathoGenesis to seek approval for tobramycin

Italian researchers report effective combination therapy for HIV-associated NHL

IND filed for SunPharm IBD treatment

Riluzole now available in France

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...